AMED:XETRA:XETRA-

| Eurozone Large-Cap Equity |

Last Closing

USD 315.35

Change

+0.80 (+0.25)%

Market Cap

USD 1.22B

Volume

38.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-02-11 )

Largest Industry Peers for Eurozone Large-Cap Equity

Symbol Name Price(Change) Market Cap
XESC:XETRA

+0.51 (+0.56%)

USD 7.37B
EXW1:XETRA

+0.31 (+0.57%)

USD 6.66B
EUN2:XETRA

+0.29 (+0.53%)

USD 3.75B
LYSX:XETRA

+0.34 (+0.58%)

USD 2.43B
EDM4:XETRA

+0.03 (+0.32%)

USD 2.37B
EMNE:XETRA

+0.04 (+0.49%)

USD 2.37B
EXSI:XETRA

+0.25 (+0.46%)

USD 2.15B
SXR7:XETRA

+0.96 (+0.50%)

USD 2.04B
ZPAB:XETRA

+0.30 (+0.85%)

USD 1.81B
SLMA:XETRA

+0.05 (+0.53%)

USD 1.50B

ETFs Containing AMED:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Eurozone Large-Cap Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.72% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.72% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 14.17% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.17% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 37.71% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.71% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 11.57% 69% C- 68% D+
Dividend Return 11.57% 68% D+ 67% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 14.95% 38% F 49% F
Risk Adjusted Return 77.40% 67% D+ 71% C-
Market Capitalization 1.22B N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.